Alexandor Kiselyov

Title: Alexandor Kiselyov: Innovator in Molecular Biology and Pharmacology

Introduction

Alexandor Kiselyov is a prominent inventor based in San Diego, CA (US). He has made significant contributions to the field of molecular biology and pharmacology. His work focuses on developing compounds that interact with estrogen receptors, which play a crucial role in various disease states.

Latest Patents

Kiselyov holds a patent for "Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof." This invention provides compounds that modulate the effects of GPR30 and the classical estrogen receptors alpha and beta (ERα and ERβ). These compounds can function as agonists and/or antagonists of the disclosed estrogen receptors. The diseases targeted by this invention include various hormone-dependent cancers, reproductive disorders, cardiovascular conditions, and neurodegenerative diseases, among others. Additionally, the invention includes a contraceptive indication to prevent or reduce the likelihood of pregnancy after intercourse.

Career Highlights

Kiselyov's career is marked by his innovative approach to addressing complex medical conditions through his research and inventions. His work has the potential to impact the treatment of numerous diseases, making him a valuable contributor to the scientific community.

Collaborations

He has collaborated with notable colleagues, including Eric R Prossnitz and Sergey E Tkatchenko. These partnerships have further enhanced the scope and impact of his research.

Conclusion

Alexandor Kiselyov is a distinguished inventor whose work in molecular biology and pharmacology is paving the way for new treatments for various diseases. His innovative compounds and collaborative efforts are significant contributions to the field.